Tags

Type your tag names separated by a space and hit enter

Regulating off-label drug use--rethinking the role of the FDA.
N Engl J Med. 2008 Apr 03; 358(14):1427-9.NEJM

Authors+Show Affiliations

Stanford Prevention Research Center, Program on Prevention Outcomes and Practices, Stanford University, Stanford, CA, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

18385495

Citation

Stafford, Randall S.. "Regulating Off-label Drug Use--rethinking the Role of the FDA." The New England Journal of Medicine, vol. 358, no. 14, 2008, pp. 1427-9.
Stafford RS. Regulating off-label drug use--rethinking the role of the FDA. N Engl J Med. 2008;358(14):1427-9.
Stafford, R. S. (2008). Regulating off-label drug use--rethinking the role of the FDA. The New England Journal of Medicine, 358(14), 1427-9. https://doi.org/10.1056/NEJMp0802107
Stafford RS. Regulating Off-label Drug Use--rethinking the Role of the FDA. N Engl J Med. 2008 Apr 3;358(14):1427-9. PubMed PMID: 18385495.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Regulating off-label drug use--rethinking the role of the FDA. A1 - Stafford,Randall S, PY - 2008/4/4/pubmed PY - 2008/4/11/medline PY - 2008/4/4/entrez SP - 1427 EP - 9 JF - The New England journal of medicine JO - N. Engl. J. Med. VL - 358 IS - 14 SN - 1533-4406 UR - https://www.unboundmedicine.com/medline/citation/18385495/Regulating_off_label_drug_use__rethinking_the_role_of_the_FDA_ L2 - http://www.nejm.org/doi/full/10.1056/NEJMp0802107?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -